Profiling the effects of rifaximin on the healthy human colonic microbiota using a chemostat model

This is a preprint and may not have undergone formal peer review

Moura, I, Buckley, A orcid.org/0000-0002-2790-0717, Ewin, D et al. (4 more authors) (2019) Profiling the effects of rifaximin on the healthy human colonic microbiota using a chemostat model. [Preprint - BioRxiv]

Abstract

Metadata

Item Type: Preprint
Authors/Creators:
Dates:
  • Published: 1 November 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Environment (Leeds) > School of Food Science and Nutrition (Leeds)
Funding Information:
Funder
Grant number
Teva Pharmaceuticals USA Inc.
TEVA
Depositing User: Symplectic Publications
Date Deposited: 08 Nov 2024 15:20
Last Modified: 08 Nov 2024 15:20
Identification Number: 10.1101/828269
Open Archives Initiative ID (OAI ID):

Export

Statistics